2019 International Congress

Tuesday, September 24, 2019

1:45pm-3:15pm

Unusual expression of fragile X premutation in a female patient: clinical and tractographic description

V. Ros-Castelló, E. Natera-Villalba, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, S. Fanjul, J. López-Sendón, A. Alonso-Cánovas, JC. Martínez-Castrillo, J. álvarez-Linera, I. Pareés (Madrid, Spain)

Dystonia  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience

V. Veerappan, M. Brodsky (Portland, OR, USA)

Dystonia  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease

G. Thomas, L. Leyland, J. Acosta-Cabronero, R. Weil (London, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies

N. Khalil, E. Matar, S. Duffy, S. Lewis (Camperdown, Australia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism

A. Margolius, D. Hengartner, O. Hogue, X. Garcia, S. Patel, A. Ahmed, H. Fernandez, XX. Yu (Bogota, Colombia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

Rating Scales  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Validation of the diagnostic criteria for progressive supranuclear palsy in pathologically confirmed patients

I. Aiba, Y. Saito, Y. Yokokawa, T. Katayama, M. Kenjo, R. Hashimoto, S. Sakakibara, M. Sato, H. Nakatsuji, A. Inukai, Y. Iwasaki, M. Mimuro, A. Akagi, M. Yoshida (Nagoya, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

Rating Scales  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Validation of the PREDIGT Score for the Incidence Rate of Parkinson disease

J. Li, T. Mestre, J. Tomlinson, M. Frasier, E. Lang, B. Mollenhauer, T. Ramsay, D. Manuel, M. Schlossmacher (Goettingen, Germany)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3